---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-177774"
form_type: "8-K"
ticker: "AVIR"
cik: "0001593899"
company_name: "Atea Pharmaceuticals, Inc."
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:24:42.785208+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Atea Pharmaceuticals stockholders elect three Class II directors, approve 'one year' say-on-pay frequency

## Summary
- Elected Bruno Lucidi, Polly A. Murphy, and Bruce Polsky as Class II directors (over 55.7M votes each, no broker non-votes included).
- Advisory vote on executive compensation frequency: ONE year approved with 59,857,505 votes for (99.4% of votes cast).
- Ratification of KPMG LLP as independent auditor for 2022 passed with 71,630,493 votes for, 281,592 against, 35,490 abstain.
- Approximately 86.41% of outstanding shares were represented at the meeting (71,947,575 shares of common stock).

## SEC filing metadata
- accession: 0001193125-22-177774
- form_type: 8-K
- ticker: AVIR
- cik: 0001593899
- company_name: Atea Pharmaceuticals, Inc.
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593899/000119312522177774/0001193125-22-177774-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593899/000119312522177774/d916865d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-177774
- JSON: https://secwatch.observer/filing/0001193125-22-177774.json
- Plain text: https://secwatch.observer/filing/0001193125-22-177774.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.